A Study of TQB3454 Tablets in Patients With Blood Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Role of BMP Pathway in MDS Progression
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
- Status
- RECRUITING
- Phase
- PHASE2
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
- Status
- RECRUITING
- Phase
- PHASE2
CyFluATG in Lower Risk MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
- Status
- COMPLETED
- Phase
- N/A
Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- Status
- RECRUITING
- Phase
- PHASE1
Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
- Status
- TERMINATED
- Phase
- PHASE1
A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS
- Status
- UNKNOWN
- Phase
- PHASE4